1. Home
  2. CASI vs VIVK Comparison

CASI vs VIVK Comparison

Compare CASI & VIVK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CASI
  • VIVK
  • Stock Information
  • Founded
  • CASI 1991
  • VIVK 2006
  • Country
  • CASI China
  • VIVK United States
  • Employees
  • CASI N/A
  • VIVK N/A
  • Industry
  • CASI Biotechnology: Pharmaceutical Preparations
  • VIVK Oilfield Services/Equipment
  • Sector
  • CASI Health Care
  • VIVK Energy
  • Exchange
  • CASI Nasdaq
  • VIVK Nasdaq
  • Market Cap
  • CASI 31.0M
  • VIVK 34.6M
  • IPO Year
  • CASI 1996
  • VIVK N/A
  • Fundamental
  • Price
  • CASI $1.89
  • VIVK $0.78
  • Analyst Decision
  • CASI Strong Buy
  • VIVK
  • Analyst Count
  • CASI 1
  • VIVK 0
  • Target Price
  • CASI $4.00
  • VIVK N/A
  • AVG Volume (30 Days)
  • CASI 8.4K
  • VIVK 53.5K
  • Earning Date
  • CASI 05-20-2025
  • VIVK 05-19-2025
  • Dividend Yield
  • CASI N/A
  • VIVK N/A
  • EPS Growth
  • CASI N/A
  • VIVK N/A
  • EPS
  • CASI N/A
  • VIVK N/A
  • Revenue
  • CASI $28,537,000.00
  • VIVK $89,811,240.00
  • Revenue This Year
  • CASI N/A
  • VIVK N/A
  • Revenue Next Year
  • CASI N/A
  • VIVK N/A
  • P/E Ratio
  • CASI N/A
  • VIVK N/A
  • Revenue Growth
  • CASI N/A
  • VIVK 51.40
  • 52 Week Low
  • CASI $1.64
  • VIVK $0.55
  • 52 Week High
  • CASI $7.67
  • VIVK $3.45
  • Technical
  • Relative Strength Index (RSI)
  • CASI 44.54
  • VIVK 43.75
  • Support Level
  • CASI $1.64
  • VIVK $0.72
  • Resistance Level
  • CASI $1.94
  • VIVK $1.08
  • Average True Range (ATR)
  • CASI 0.09
  • VIVK 0.11
  • MACD
  • CASI -0.00
  • VIVK -0.02
  • Stochastic Oscillator
  • CASI 55.77
  • VIVK 14.74

About CASI CASI Pharmaceuticals Inc.

CASI Pharmaceuticals Inc is a biopharmaceutical company that focuses on commercializing therapeutics and pharmaceutical products. The products include injections for patients who are suffering from leukemias and lymphomas. The EVOMELA injection is used as a conditioning treatment before autologous stem cell transplant for patients with multiple myeloma. The company products include CID-103, CNCT19, EVOMELA, MARQIBO, ZEVALIN, ENMD-2076 and others. The majority of the revenue is generated from the product sales of EVOMELA.

About VIVK Vivakor Inc.

Vivakor Inc is a socially responsible operator, acquirer and developer of technologies and assets in the oil and gas industry, as well as related environmental solutions. It is primarily focused on operating crude oil gathering, storage and transportation facilities, as well as contaminated soil remediation services.

Share on Social Networks: